Valeur Intrinsèque du S&P et Nasdaq Contactez-nous

Heska Corporation HSKA NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score
53/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$159.50
+32.9%

Heska Corporation (HSKA) est une société cotée en bourse dans le Santé secteur, opérant dans le Medical - Devices secteur d'activité. Le siège social de l'entreprise est situé à Loveland, CO, United States. Le PDG actuel est Kevin S. Wilson.

HSKA a date d'introduction en bourse 1997-07-01, 808 employés à temps plein, cotée sur le NASDAQ Capital Marke, une capitalisation boursière de $1.31B.

À propos de Heska Corporation

Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels, and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; and turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force, and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was founded in 1988 and is based in Loveland, Colorado.

📍 3760 Rocky Mountain Avenue, Loveland, CO 80538 📞 970 493 7272
Détails de l'Entreprise
SecteurSanté
IndustrieMedical - Devices
PaysUnited States
BourseNASDAQ Capital Marke
DeviseUSD
Date d'IPO1997-07-01
PDGKevin S. Wilson
Employés808
Informations de Trading
Prix Actuel$119.99
Capitalisation Boursière$1.31B
Plage 52 Semaines57.83-120.03
Bêta1.60
ETFNon
ADRNon
CUSIP42805E306
Contactez-nous
🎓
SharesGrow Académie
Apprenez à calculer la Valeur Intrinsèque et trouver des actions sous-évaluées.
Sessions hebdomadaires en direct
Envoyez-nous un message